Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases
口服选择性GPR120/FFA4激动剂化合物A并不能有效缓解典型自身免疫性疾病小鼠模型中的组织炎症。
期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.438
Wannick, Melanie; Bezdek, Siegfried; Guillen, Nathalie; Thieme, Markus; Meshrkey, Fibi; Mousavi, Sadegh; Seeling, Michaela; Nimmerjahn, Falk; Mócsai, Attila; Zillikens, Detlef; Sezin, Tanya; Sadik, Christian D
